Glenmark Pharmaceuticals Limited Share Price Bombay S.E.
Stocks
GLENMARK
INE935A01035
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,301.40 INR | +0.84% |
|
+4.14% | +13.04% |
| 07-07 | India finds Adani's Mumbai airport shops sold nicotine pouches in breach of law | RE |
| 07-06 | Glenmark Pharmaceuticals Launches Olanzapine for Injection | MT |
| Market Cap | 649B 6.79B 5.95B 5.51B 5.07B 9.59B 9.78B 65.7B 25.77B 319B 25.48B 24.92B 1,101B | P/E 2026 |
44.2x | P/E 2027 * | 27.6x |
|---|---|---|---|---|---|
| Enterprise Value | 610B 6.37B 5.59B 5.18B 4.76B 9.01B 9.19B 61.72B 24.21B 300B 23.94B 23.41B 1,035B | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.67x |
| Free-Float |
51.03% | Yield 2026 |
0.12% | Yield 2027 * | 0.23% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | +0.84% | ||
| 1 week | +4.14% | ||
| Current month | +4.38% | ||
| 1 month | +5.90% | ||
| 3 months | +6.40% | ||
| 6 months | +14.03% | ||
| Current year | +13.04% |
| 1 week | 2,214.85 |  | 2,322.95 |
| 1 month | 2,109 | | 2,322.95 |
| Current year | 1,842.8 | | 2,471.05 |
| 1 year | 1,794 | | 2,471.05 |
| 3 years | 681.6 | | 2,471.05 |
| 5 years | 348.9 | | 2,471.05 |
| 10 years | 168 | | 2,471.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 31/12/1999 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 26/05/2025 |
Indrajit Bose
PSD | President | - | 14/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 11/05/2011 | |
| Director/Board Member | 85 | 13/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.84% | +4.14% | - | - | 6.75B | |
| -0.73% | +0.87% | +14.92% | +78.11% | 48.69B | |
| -2.01% | -3.01% | +63.83% | +113.44% | 36.38B | |
| -0.88% | -2.16% | -3.93% | +39.57% | 12.19B | |
| -1.69% | -0.82% | +15.49% | +90.65% | 12.04B | |
| +2.68% | +0.38% | +31.49% | +122.13% | 9.04B | |
| -1.57% | -3.25% | +17.24% | +36.55% | 7.09B | |
| -1.13% | -0.76% | +48.87% | -5.59% | 7.06B | |
| -5.52% | -12.48% | -22.06% | +9.45% | 6.1B | |
| +2.17% | +2.86% | +30.26% | +140.30% | 4.38B | |
| Average | -0.66% | -1.00% | +21.79% | +69.40% | 15.89B | |
| Weighted average by Cap. | -0.96% | -0.15% | +27.53% | +80.43% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 153B 1.6B 1.4B 1.3B 1.2B 2.26B 2.31B 15.49B 6.07B 75.19B 6.01B 5.88B 260B | 167B 1.74B 1.53B 1.42B 1.3B 2.46B 2.51B 16.87B 6.61B 81.87B 6.54B 6.4B 283B |
| Net income | 20.53B 215M 188M 174M 160M 303M 309M 2.08B 815M 10.08B 806M 788M 34.82B | 23.28B 243M 213M 198M 182M 344M 351M 2.36B 924M 11.43B 913M 893M 39.49B |
| Net Debt | -39.29B -411M -360M -334M -307M -580M -592M -3.97B -1.56B -19.3B -1.54B -1.51B -66.64B | -37.12B -388M -340M -315M -290M -548M -559M -3.76B -1.47B -18.23B -1.46B -1.42B -62.96B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/07/26 | ₹2,301.40 | +0.84% | 19,902 |
| 10/07/26 | ₹2,282.25 | +0.75% | 9,745 |
| 09/07/26 | ₹2,265.25 | +1.86% | 22,069 |
| 08/07/26 | ₹2,223.85 | -1.75% | 10,353 |
| 07/07/26 | ₹2,263.45 | -0.31% | 17,397 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
- GLENMARK Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
